Human Lumican Antibody Summary
Gln19-Asn338
Accession # P51884
*Small pack size (-SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Detection of Human Lumican by Western Blot. Western blot shows lysates of human colon tissue. PVDF membrane was probed with 1 µg/mL of Goat Anti-Human Lumican Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2846) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF019). A specific band was detected for Lumican at approximately 60-85 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
View Larger
Lumican in Human Kidney. Lumican was detected in immersion fixed paraffin-embedded sections of human kidney using Goat Anti-Human Lumican Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2846) at 15 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). Specific staining was localized to convoluted tubules. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
View Larger
Detection of Human Lumican by Simple WesternTM. Simple Western shows lysates of human colon tissue, loaded at 0.5 mg/ml. A specific band was detected for Lumican at approximately 100-180 kDa (as indicated) using 10 µg/mL of Goat Anti-Human Lumican Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2846). This experiment was conducted under reducing conditions and using the 12-230kDa separation system.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Lumican
Lumican is a 40 kDa member of the family of small leucine-rich repeat proteoglycans (SLRPs) and the class II subfamily (1). Human Lumican is synthesized as a 338 amino acid (aa) precursor that contains an 18 aa signal sequence and a 320 aa mature chain. The mature chain contains a negatively charged N-terminal domain containing sulfated tyrosine and disulfide bonds, 12 leucine-rich repeats (LRRs), four potential sites of N-linked glycosylation, and a carboxyl terminal domain containing two conserved cysteines (1). Mature human Lumican is 88%, 87%, and 70% aa identical to mature mouse, rat, and chick Lumican, respectively. SLRPs constitute an important fraction of noncollagenous extracellular matrix proteins (ECM) proteins (1, 2). Lumican is expressed in a variety of tissues, including skin, artery, lung, cornea, kidney, bone, aorta, and articular cartilage (1). Lumican’s role in vivo has been found using Lumican null mice. These mice have functional deficits including corneal opacity as well as skin and tendon fragility associated with disorganized and loosely packed collagen fibers (1, 3‑6). The abnormal connective tissue phenotype seen in the Lumican null mice shows the importance of the role of Lumican in collagen fibrillogenesis (1). In addition to the control of collagen fibril assembly, Lumican has been shown to play a role in the regulation of cell proliferation (7, 8), migration (8, 9), and adhesion (9). Lumican’s overexpression has been reported in carcinoid tumor, breast, colorectal, neuroendocrine, uterine cervical and pancreatic cancers (10).
- Nikitovic, D. et al. (2008) IUBMB Life 60:818.
- Blochberger, T.C. et al. (1992) J. Biol. Chem. 267:347.
- Chakravarti, S. et al. (1998) J. Cell Biol. 141:1277.
- Chakravarti, S. et al. (2000) Invest. Ophthalmol. Vis. Sci. 41:3365.
- Jepsen, K.J. et al. (2002) J. Biol. Chem. 277:35532.
- Chakravarti, S. et al. (2003) Invest. Ophthalmol. Vis. Sci. 44:2422.
- Vuillermoz, B. et al. (2004) Exp. Cell Res. 296:294.
- Nikitovic, D. et al. (2008) FEBS J. 275:350.
- D’Onofrio, M.F. et al. (2008) Biochem. Biophys. Res. Commun. 365:266.
- Ishiwata, T. et al. (2007) Oncol. Rep. 18:537.
Product Datasheets
Citations for Human Lumican Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
15
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition
Authors: X Li, D Roife, Y Kang, B Dai, M Pratt, J B Fleming
Oncogene
-
Leptolysin, a Leptospira secreted metalloprotease of the pappalysin family with broad-spectrum activity
Authors: Daniella dos Santos Courrol, Cristiane Castilho Fernandes da da Silva, Luan Gavião Prado, Rosa Maria Chura-Chambi, Ligia Morganti, Gisele Oliveira de Souza et al.
Frontiers in Cellular and Infection Microbiology
-
Lumican deficiency results in cardiomyocyte hypertrophy with altered collagen assembly
Authors: Loren E. Dupuis, Matthew G. Berger, Samuel Feldman, Lorna Doucette, Vennece Fowlkes, Shukti Chakravarti et al.
Journal of Molecular and Cellular Cardiology
-
Development of stromal differentiation patterns in heterotypical models of artificial corneas generated by tissue engineering
Authors: Blanco-Elices C, Morales-�lvarez C, Chato-Astrain J et al.
Frontiers in Bioengineering and Biotechnology
-
Development of stromal differentiation patterns in heterotypical models of artificial corneas generated by tissue engineering
Authors: Blanco-Elices C, Morales-�lvarez C, Chato-Astrain J et al.
Frontiers in Bioengineering and Biotechnology
-
Identifying new biomarkers of aggressive Group�3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging
Authors: F Linke, JEC Johnson, S Kern, CD Bennett, A Lourdusamy, D Lea, SC Clifford, CLR Merry, S Stolnik, MR Alexander, AC Peet, DJ Scurr, RL Griffiths, AM Grabowska, ID Kerr, B Coyle
Acta neuropathologica communications, 2023-01-11;11(1):6.
Species: Human
Sample Types: Whole Cells
Applications: IHC -
Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma
Authors: X Li, Y Lee, Y Kang, B Dai, MR Perez, M Pratt, EJ Koay, M Kim, RA Brekken, JB Fleming
Cell Death Differ., 2018-10-03;26(2):382-393.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery.
Authors: Li X, Truty M, Kang Y, Chopin-Laly X, Zhang R, Roife D, Chatterjee D, Lin E, Thomas R, Wang H, Katz M, Fleming J
Clin Cancer Res, 2014-10-21;20(24):6529-40.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Resistance of corneal RFUVA-cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.
Authors: Zhang Y, Mao X, Schwend T, Littlechild S, Conrad G
Invest Ophthalmol Vis Sci, 2013-02-05;54(2):1014-25.
Species: Human
Sample Types: Protein
Applications: Western Blot -
Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.
Authors: Krishnan A, Li X, Kao W, Viker K, Butters K, Masuoka H, Knudsen B, Gores G, Charlton M
Lab Invest, 2012-09-24;92(12):1712-25.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-P -
Effects of Ultraviolet-A and Riboflavin on the Interaction of Collagen and Proteoglycans during Corneal Cross-linking.
Authors: Zhang Y, Conrad AH, Conrad GW
J. Biol. Chem., 2011-02-18;286(15):13011-22.
Species: Bovine
Sample Types: Tissue Homogenates
Applications: Western Blot -
HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.
Authors: Wu J, Liu Z, Shao C, Gong Y, Hernando E, Lee P, Narita M, Muller W, Liu J, Wei JJ
Cancer Res., 2011-01-11;71(2):349-59.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Vascular Endothelial Growth Factor (VEGF) Induced Downstream Responses to Transient Receptor Potential Vanilloid 1 (TRPV1) and 3-Iodothyronamine (3-T1AM) in Human Corneal Keratocytes
Authors: Ersal Türker, Fabian Garreis, Noushafarin Khajavi, Peter S. Reinach, Pooja Joshi, Tobias Brockmann et al.
Front Endocrinol (Lausanne)
-
The Downregulation of Placental Lumican Promotes the Progression of Preeclampsia
Authors: Chao Liu, Yulian Hu, Zhongying Wang, Hua Pan, Yan Ren, Xiao Li et al.
Reproductive Sciences
-
Corneal keratocyte transition to mesenchymal stem cell phenotype and reversal using serum-free medium supplemented with fibroblast growth factor-2, transforming growth factor-beta 3 and retinoic acid
Authors: Laura E. Sidney, Andrew Hopkinson
Journal of Tissue Engineering and Regenerative Medicine
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human Lumican Antibody
There are currently no reviews for this product. Be the first to review Human Lumican Antibody and earn rewards!
Have you used Human Lumican Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
